These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases]. Aleksandrova EN; Zimin IuI; Nasonov EL Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315 [No Abstract] [Full Text] [Related]
7. Effect of vitamin A treatment on immune reactivity and lipid peroxidation in patients with Sjögren's syndrome. Szöcsik K; González-Cabello R; Vien CV; Mézes M; Szongoth M; Gergely P Clin Rheumatol; 1988 Dec; 7(4):514-9. PubMed ID: 3246135 [TBL] [Abstract][Full Text] [Related]
8. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number. Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772 [TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent cell-mediated cytotoxicity by peripheral blood mononuclear cells from patients with Sjögren's syndrome, with special reference to differentiation from phagocytic activity. Ichikawa Y; Takaya M; Arimori S Tokai J Exp Clin Med; 1980 Jan; 5(1):83-90. PubMed ID: 7385266 [TBL] [Abstract][Full Text] [Related]
10. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome. Pedersen BK; Oxholm P Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548 [TBL] [Abstract][Full Text] [Related]
11. [Preliminary study on the activity of natural killer cells in patients with Sjogren's syndrome]. Wang JM Zhonghua Kou Qiang Yi Xue Za Zhi; 1988 Jul; 23(4):244-6. PubMed ID: 3234131 [No Abstract] [Full Text] [Related]
12. Impaired indomethacin-boosting of the defective natural killer cell activity in patients with primary Sjögren's syndrome. Pedersen BK; Oxholm P; Manthorpe R; Andersen V Scand J Rheumatol Suppl; 1986; 61():135-8. PubMed ID: 3473621 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome. Pedersen BK; Oxholm P; Manthorpe R; Andersen V Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480 [TBL] [Abstract][Full Text] [Related]
16. Natural cell-mediated cytotoxicity in Sjögren's syndrome and rheumatoid arthritis. Goto M; Tanimoto K; Chihara T; Horiuchi Y Arthritis Rheum; 1981 Nov; 24(11):1377-82. PubMed ID: 7317114 [TBL] [Abstract][Full Text] [Related]
17. [Etiopathogenic aspects of Sjögren's syndrome]. Palomino Nicas J; Villar Ortiz J; Viciana Fernández P; Piedra Priego J; Carneado de la Fuente J Rev Clin Esp; 1984 Jun 15-30; 173(5-6):253-8. PubMed ID: 6387825 [No Abstract] [Full Text] [Related]
18. [Renal tubular acidosis and Sjogren's syndrome]. Tanikawa K; Ebata H; Tanaka M; Yamakata Y Nihon Rinsho; 1985 Sep; 43(9):1944-9. PubMed ID: 3912554 [No Abstract] [Full Text] [Related]
19. Characterization of the phenotype and function of lymphocytes infiltrating the salivary gland in patients with primary Sjogren syndrome. Fox RI; Adamson TC; Fong S; Young C; Howell FV Diagn Immunol; 1983; 1(3):233-9. PubMed ID: 6238753 [TBL] [Abstract][Full Text] [Related]
20. Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. Fox RI; Hugli TE; Lanier LL; Morgan EL; Howell F J Immunol; 1985 Jul; 135(1):207-14. PubMed ID: 3923102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]